Exoskeleton Market Size & Growth Forecast 2027–2036, By Segments (Mobility, Technology, Extremity, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 14029| Published Date: Jul-2026| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Exoskeleton Market size was valued at USD 694.46 million in 2026 and is anticipated to grow at a 13.78% CAGR from 2027 to 2036, attaining USD 2.53 billion by 2036. The industry revenue for 2027 is calculated at USD 775.02 million.

Base Year Value (2026)
USD 694.46 million
CAGR (2027-2036)
13.78%
Forecast Year Value (2036)
USD 2.53 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Exoskeleton Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 47.84% share in 2026, supported by early adoption across healthcare, industrial, and defense sectors, along with strong rehabilitation infrastructure and enterprise procurement capacity.
  • Asia Pacific is expected to expand at an 18.48% CAGR, driven by industrial automation, investment in advanced medical devices, and growing adoption of rehabilitation technologies and ergonomic workplace solutions.

Segment Momentum

  • Mobile exoskeletons captured 60.52% of the market in 2026 because their portability supports rehabilitation, industrial, and assistive applications, allowing deployment across diverse real-world environments with greater operational flexibility.
  • Non-powered exoskeletons are growing rapidly as organizations seek lightweight, cost-effective ergonomic support that reduces fatigue without requiring batteries, charging, or complex system maintenance.

Market Expansion Drivers

  • Aging population and rising stroke and spinal cord injury cases driving rehabilitation exoskeleton demand.
  • Increasing industrial musculoskeletal disorders driving workplace exoskeleton adoption for injury prevention.
  • Expanding insurance reimbursement and AI-enabled wearable robotics improving accessibility and clinical deployment.

Leading Market Participants

  • Major players in the exoskeleton market include Ekso Bionics Holdings, Inc. (United States), CYBERDYNE Inc. (Japan), ReWalk Robotics Ltd. (Israel), Lockheed Martin Corporation (United States), Hocoma AG (Switzerland), SuitX (United States), Rex Bionics Ltd. (New Zealand), Panasonic Holdings Corporation (Japan), DIH Medical (China), Ottobock SE & Co. KGaA (Germany).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 694.46 million
  • 2027 Estimated Market Size: USD 775.02 million.
  • Projected Market Size: USD 2.53 billion by 2036
  • Growth Forecast: 13.78% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Mobile (Mobility) | Powered (Technology) | Lower Body (Extremity) | Healthcare (End Use)
  • Emerging Opportunity Segment: Mobile (Mobility) | Non-powered (Technology) | Upper Body (Extremity) | Industry (End Use)
Market Dynamics

Market Growth Drivers and Industry Trends

Aging population and rising stroke and spinal cord injury cases driving rehabilitation exoskeleton demand

The exoskeleton market is benefiting from the growing need for rehabilitation support as aging populations and increasing cases of stroke and spinal cord injuries create greater demand for assistive technologies. Rehabilitation exoskeletons can support structured movement training and help patients perform repetitive mobility exercises under clinical supervision.

Increasing industrial musculoskeletal disorders driving workplace exoskeleton adoption for injury prevention

Workplace-related musculoskeletal disorders are encouraging greater adoption of wearable support technologies, strengthening the exoskeleton market across industrial environments. Exoskeletons can assist workers during physically demanding activities by reducing strain during repetitive or load-intensive tasks, supporting injury prevention and improving ergonomic conditions.

Expanding insurance reimbursement and AI-enabled wearable robotics improving accessibility and clinical deployment

Expanding insurance reimbursement can improve access to advanced rehabilitation technologies, while AI-enabled wearable robotics are enhancing the functionality of the exoskeleton market. Intelligent systems can adapt assistance to user movement and rehabilitation requirements, supporting broader clinical deployment and making wearable robotic technologies more practical for patient care.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Aging population and rising stroke and spinal cord injury cases driving rehabilitation exoskeleton demand 2.00% High North America, Europe High Near Term
Increasing industrial musculoskeletal disorders driving workplace exoskeleton adoption for injury prevention 1.80% Moderate Asia Pacific, North America Medium Mid Term
Expanding insurance reimbursement and AI-enabled wearable robotics improving accessibility and clinical deployment 1.60% High Europe, North America Medium Mid Term

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Exoskeleton Market
Largest Region
North America
47.84% Market Share in 2026

North America (Largest Region)

North America accounted for a 47.84% share of the exoskeleton market in 2026, supported by advanced healthcare infrastructure, strong rehabilitation capabilities, and growing interest in technologies that enhance mobility and physical assistance. Demand is being encouraged by applications in rehabilitation, workplace safety, logistics, and industrial operations, where exoskeletons can assist movement, reduce physical strain, and support worker productivity. The region's established robotics and wearable technology ecosystem also facilitates product development and integration with healthcare and industrial workflows. Increasing attention to occupational ergonomics and rehabilitation outcomes, together with continued innovation in lightweight and sensor-enabled systems, is strengthening regional adoption.

Asia Pacific (Fastest-Growing Region)

Asia Pacific represents the fastest-growing regional market, driven by expanding industrial automation, manufacturing activity, and healthcare modernization. Increasing workplace safety requirements and efforts to reduce musculoskeletal strain are creating opportunities for wearable robotic technologies across industrial environments. At the same time, improvements in rehabilitation infrastructure and greater awareness of assistive technologies are supporting healthcare applications. Growing investment in robotics, electronics, and advanced manufacturing capabilities is also encouraging development of more accessible exoskeleton systems, while the region's expanding workforce and industrial base provide a broad application landscape.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation HubiScaleNascentDeveloping Advanced
Cost-Sensitive RegioniScaleLowMedium High
Regulatory EnvironmentiScaleRestrictiveNeutral Supportive
Demand DriversiScaleWeakModerate Strong
Development StageiScaleEmergingDeveloping Developed
Adoption RateiScaleLowMedium High
New Entrants / StartupsiScaleSparseModerate Dense
Macro IndicatorsiScaleWeakStable Strong
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Industrial Workforce Support

Germany emphasizes exoskeleton adoption within manufacturing and logistics to improve worker ergonomics and reduce physical strain. Companies collaborate with industrial employers to refine wearable systems that integrate efficiently into existing operational environments.

France 🇫🇷

Rehabilitation Technology Focus

France supports exoskeleton deployment through rehabilitation centers and medical technology initiatives. Companies emphasize patient mobility outcomes, clinician usability, and collaborative research that strengthens practical healthcare adoption of wearable robotic systems.

Italy 🇮🇹

Assistive Mobility Development

Italy expands exoskeleton applications through rehabilitation facilities and industrial workplace initiatives. Manufacturers focus on adaptable wearable systems, user-centered design, and partnerships with healthcare organizations to improve mobility assistance and occupational support.

Japan 🇯🇵

Aging Care Applications

Japan applies exoskeleton technologies to rehabilitation services and elderly care as healthcare providers seek mobility assistance solutions. Product development focuses on compact designs, user comfort, and dependable long-term operation for clinical and caregiving environments.

South Korea 🇰🇷

Robotics Integration Strategy

South Korea combines robotics expertise with exoskeleton innovation for industrial and medical applications. Developers invest in intelligent control systems, lightweight materials, and wearable technologies that enhance usability across multiple commercial settings.

United States 🇺🇸

Clinical Adoption Momentum

The U.S. exoskeleton market advances through rehabilitation, workplace safety, and defense applications. Developers prioritize clinical validation, ergonomic improvements, and software integration to expand practical deployment across healthcare providers and industrial users.

Exoskeleton Market Share (%), by Mobility, 2026

60.52%
Mobile
Fixed/Stationary

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Mobility Segment Analysis: Mobile (Largest & Fastest-Growing Segment)

The mobile segment led the exoskeleton market and was also the fastest-growing mobility segment, accounting for a 60.52% share in 2026. Mobile exoskeletons provide users with greater freedom of movement while delivering physical assistance during rehabilitation, industrial tasks, and mobility-support applications. Their ability to augment strength, endurance, and movement without restricting users to fixed locations makes them attractive across a broad range of use cases. Increasing interest in assistive technologies, workforce ergonomics, and rehabilitation solutions is strengthening demand for mobile exoskeleton systems.

Technology Segment Analysis: Powered (Largest Segment) vs Non-powered (Fastest-Growing Segment)

Powered exoskeletons held the largest share of the exoskeleton market in 2026. Their leading position reflects the ability to actively assist users through motors, actuators, and electronic control systems, providing support for movement, lifting, walking, or rehabilitation activities. Technological improvements in sensing, control, battery systems, and wearable design are enhancing the functionality of powered systems and expanding their applicability. Demand from healthcare and occupational settings, where controlled assistance can reduce physical strain or support mobility, continues to reinforce the segment's established position.

Non-powered exoskeletons are experiencing faster growth as organizations and users seek lightweight, mechanically assisted solutions that can provide physical support without reliance on powered actuation. These systems can reduce muscular strain during repetitive or physically demanding activities while offering relatively simple operation. Their suitability for industrial ergonomics, workplace assistance, and mobility support is encouraging wider adoption. Growing attention to worker safety and fatigue reduction is further increasing interest in practical exoskeleton designs that can be deployed across varied operating environments.

Segment Sub-Segment Largest Segment Fastest Growing
Mobility Mobile, Fixed/Stationary Mobile Mobile
Technology Powered, Non-powered Powered Non-powered
Extremity Upper Body, Lower Body, Full Body Lower Body Upper Body
End Use Healthcare, Military, Industry Healthcare Industry
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

Prominent players in the exoskeleton market:

1. Ekso Bionics Holdings Inc. (United States)

2. CYBERDYNE Inc. (Japan)

3. ReWalk Robotics Ltd. (Israel)

4. Lockheed Martin Corporation (United States)

5. Hocoma AG (Switzerland)

6. SuitX (United States)

7. Rex Bionics Ltd. (New Zealand)

8. Panasonic Holdings Corporation (Japan)

9. DIH Medical (China)

10. Ottobock SE & Co. KGaA (Germany)

The exoskeleton market is advancing through rapid integration of robotics and assistive mobility technologies. Enhanced mechanical design is improving user adaptability and movement support. The exoskeleton market is also driven by ongoing innovation aimed at increasing rehabilitation effectiveness and industrial usability.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Ekso Bionics Holdings Inc. (United States)
CYBERDYNE Inc. (Japan)
ReWalk Robotics Ltd. (Israel)
Lockheed Martin Corporation (United States)
Hocoma AG (Switzerland)
SuitX (United States)
Rex Bionics Ltd. (New Zealand)
Panasonic Holdings Corporation (Japan)
DIH Medical (China)
Ottobock SE & Co. KGaA (Germany).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
INDUSTRY NEWS

Industry Development/News

Company Name Date Key Development
Ascentiz Jan-26 Ascentiz unveiled the modular H+K exoskeleton system at CES 2026, featuring upgraded knee modules and high-power hip modules. The system integrates BodyOS and AI-driven motion recognition to provide adaptive support across diverse terrains, enhancing user endurance and stability while reducing joint impact, marking a significant advancement in consumer-focused wearable robotics for outdoor and athletic applications.
OYMotion Technology Jan-26 OYMotion Technology partnered with Melexis to integrate advanced sensor technology into its rehabilitation and assistive robotics portfolio. The collaboration focuses on enhancing robot perception and control for dexterous hands and lower-limb exoskeletons, leveraging OYMotion's expertise in EMG/EEG AI and lightweight mechanical design to accelerate the commercialization of high-precision devices for clinical and industrial sectors.
Hippos Exoskeleton Nov-25 Hippos Exoskeleton unveiled an AI-driven, textile-based knee sleeve designed to prevent ACL injuries through integrated micro-airbag technology. The system uses on-device AI to analyze biomechanical data in real-time and deploy stabilization within 50 milliseconds during high-risk maneuvers. This development represents a shift toward soft, wearable robotics aimed at real-time injury prevention in professional athletics and military operations.
Wandercraft May-25 Wandercraft initiated clinical trials for its Personal Exoskeleton, a self-balancing wearable device engineered for individuals with severe mobility impairments. By utilizing AI-powered mechanisms to restore natural gait and posture, the company aims to move beyond clinical rehabilitation environments into personal, hands-free mobility, potentially providing wheelchair users with increased autonomy and significant improvements in functional independence.
German Bionic Jan-25 German Bionic launched the Apogee ULTRA, its most powerful industrial exoskeleton capable of providing up to 36 kg of lifting support. Designed for logistics, manufacturing, and healthcare environments, the device employs machine learning to adapt to user physiology and tasks, addressing critical labor shortages and worker safety requirements through high-capacity augmentation and data-driven performance monitoring.
RoboCT Dec-24 RoboCT’s UGO Series rehabilitation exoskeleton received CE certification as a medical device. This regulatory milestone, supported by passing international safety and performance standards, facilitates the company's strategic expansion into the European Union market, allowing it to provide standardized, robot-assisted physical therapy solutions for patients with lower-limb motor dysfunction and neurological conditions.
Wandercraft Mar-24 Wandercraft secured $75 million in Series D funding, supported by a strategic partnership with Renault, to accelerate the development of its exoskeleton portfolio, including the Atalante X and Eve models. This capital injection enhances the company's capabilities in scaling production and deploying advanced rehabilitation robotics for clinical settings, while also supporting its broader R&D programs in humanoid robotics.
Nike Mar-24 Nike entered the wearable robotics space with the unveiling of Project Amplify, a powered footwear system for lower-limb augmentation. The system provides robotic assistance to optimize movement efficiency and endurance during running and walking, signaling a strategic convergence between high-performance athletic footwear design and medical-grade exoskeleton technology.
Ekso Bionics Dec-22 Ekso Bionics acquired the Human Motion and Control business unit from Parker Hannifin, including the established Indego lower-limb exoskeleton product line. This acquisition significantly strengthened Ekso Bionics’ market position in medical rehabilitation, expanding its portfolio of powered orthotic devices and accelerating its R&D capabilities in robot-assisted physical therapy and patient-centered mobility solutions.
CYBERDYNE Inc. Jun-22 CYBERDYNE Inc. formed a strategic alliance with LIFESCAPES and entered a collaborative agreement with Malaysia’s Social Security Organization (SOCSO) to expand its Cybernics Treatment programs. By integrating its hybrid assistive limb (HAL) technology into clinical rehabilitation services, the company has broadened its international operational footprint and solidified its role in evidence-based robotic treatment for patients with severe paralysis.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Exoskeleton Market — Custom Segments

Segment Sub-Segment
Distribution Channel Direct Sales, Distributors & Dealers, System Integrators, Rental & Leasing
User Need / Application Objective Rehabilitation, Mobility Assistance, Workplace Augmentation, Strength Enhancement
Control Interface Manual Control, Sensor-Based Control, Gesture/Motion Control, Bioelectric Control

Exoskeleton Market — Custom TOC

Custom Chapter Chapter Details
Rehabilitation Adoption Pathways
  • Clinical Rehabilitation Application Landscape
  • Patient Selection and Treatment Integration
  • Provider Adoption Drivers
  • Care Delivery and Implementation Models
  • Long-Term Clinical Adoption Outlook
Industrial Workforce Augmentation
  • Industrial Use Case Landscape
  • Worker Safety and Ergonomic Applications
  • Productivity and Workforce Enhancement
  • Deployment Requirements Across Industries
  • Commercial Adoption Opportunities
Human-Robot Collaboration
  • Human-Machine Collaboration Trends
  • Workplace Integration Models
  • Safety and Interaction Requirements
  • Intelligent Assistance Technologies
  • Future Collaboration Opportunities

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

What is the current revenue of the exoskeleton market?

The market valuation of the exoskeleton is USD 775.02 million in 2027.

How much is the exoskeleton industry expected to grow by 2036?

Exoskeleton Market size was valued at USD 694.46 million in 2026 and is anticipated to grow at a 13.78% CAGR from 2027 to 2036, attaining USD 2.53 billion by 2036.

How is rehabilitation demand from aging populations and injury cases shaping exoskeleton adoption?

Increasing elderly populations and rising stroke and spinal cord injury cases are driving rehabilitation adoption of exoskeletons. These systems enable repetitive gait training, extend therapy capacity, and support assisted ambulation, helping providers manage higher patient volumes more efficiently.

How are workplace musculoskeletal disorders influencing industrial adoption of exoskeleton systems?

Rising musculoskeletal disorders in industrial settings are driving adoption of exoskeletons for targeted tasks such as lifting, overhead work, and repetitive bending. Employers use them to reduce fatigue, injury rates, and absenteeism within ergonomics-driven safety programs.

Why is the mobile segment leading the exoskeleton market?

Mobile exoskeletons captured 60.52% of the market in 2026 because their portability supports rehabilitation, industrial, and assistive applications, allowing deployment across diverse real-world environments with greater operational flexibility.

Why is non-powered technology the fastest-growing segment in the exoskeleton market?

Non-powered exoskeletons are growing rapidly as organizations seek lightweight, cost-effective ergonomic support that reduces fatigue without requiring batteries, charging, or complex system maintenance.

What factors make North America the largest exoskeleton market?

North America held a 47.84% share in 2026, supported by early adoption across healthcare, industrial, and defense sectors, along with strong rehabilitation infrastructure and enterprise procurement capacity.

Why is Asia Pacific the fastest-growing region for the exoskeleton market?

Asia Pacific is expected to expand at an 18.48% CAGR, driven by industrial automation, investment in advanced medical devices, and growing adoption of rehabilitation technologies and ergonomic workplace solutions.

Which companies are driving growth in the exoskeleton landscape?

Major players in the exoskeleton market include Ekso Bionics Holdings, Inc. (United States), CYBERDYNE Inc. (Japan), ReWalk Robotics Ltd. (Israel), Lockheed Martin Corporation (United States), Hocoma AG (Switzerland), SuitX (United States), Rex Bionics Ltd. (New Zealand), Panasonic Holdings Corporation (Japan), DIH Medical (China), Ottobock SE & Co. KGaA (Germany).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
12k+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →